$2.6 million has Been Granted to Researchers Working on Reducing the Side-Effects of Checkpoint Inhibitor Immunotherapies For Cancer Patients
Source: Pixabay

$2.6 million has Been Granted to Researchers Working on Reducing the Side-Effects of Checkpoint Inhibitor Immunotherapies For Cancer Patients

The Melanoma Research Alliance (MRA) and The American Cancer Society (ACS) have announced the first recipients of their new research grants, reports PRNewswire. The grants have been set up as…

Continue Reading $2.6 million has Been Granted to Researchers Working on Reducing the Side-Effects of Checkpoint Inhibitor Immunotherapies For Cancer Patients
A New Drug Combination May Provide an Effective Treatment for Chronic Lymphocytic Leukemia
Source: Pixabay

A New Drug Combination May Provide an Effective Treatment for Chronic Lymphocytic Leukemia

A phase 3 Murano clinical trial has shown that combining the drugs Venclexta (venetoclax) and Rituxan (rituximab) could be an effective treatment for chronic lymphocytic leukaemia, reports Cancer Updates, Research,…

Continue Reading A New Drug Combination May Provide an Effective Treatment for Chronic Lymphocytic Leukemia
A Treatment for Thrombotic Microangiopathy Has Been Awarded Breakthrough Status by the F.D.A.
Source: Pixabay

A Treatment for Thrombotic Microangiopathy Has Been Awarded Breakthrough Status by the F.D.A.

The US Food and Drug Administration (FDA) has just awarded Breakthrough Therapy Designation to a drug (OMS721) being developed to treat thrombotic microangiopathy that has developed as a result of haematopoietic stem…

Continue Reading A Treatment for Thrombotic Microangiopathy Has Been Awarded Breakthrough Status by the F.D.A.
Teens and Young Adults are Less Likely to Stick to Follow-up Guidelines After Cancer Treatment
source: pixabay.com

Teens and Young Adults are Less Likely to Stick to Follow-up Guidelines After Cancer Treatment

According to a story from The European Society For Medical Oncology, a recent study shows that young adults and teenagers are less likely to adhere to follow-up guidelines following treatment…

Continue Reading Teens and Young Adults are Less Likely to Stick to Follow-up Guidelines After Cancer Treatment
New Study Explains Why Elephants Don’t Get Cancer and Could Lead to New Treatments For Humans
Source: Pixabay

New Study Explains Why Elephants Don’t Get Cancer and Could Lead to New Treatments For Humans

A team lead by geneticist Christopher Gregg from the University of Utah conducted a study on elephant genes that discovered why elephants don't get cancer, reported by News 4 Tucson.…

Continue Reading New Study Explains Why Elephants Don’t Get Cancer and Could Lead to New Treatments For Humans